GLP-1 receptor agonists slow gastric emptying but do not directly interact with reproductive hormones like oestrogen or progesterone Semaglutide (Wegovy) and liraglutide (Saxenda) do not require routine additional contraceptive precautions based on current evidence Tirzepatide reduces oral contraceptive exposure and requires barrier methods or non-oral contraception for 4 weeks after starting and after each dose increase Long-acting reversible contraceptives (IUDs, implants) are unaffected by gastric emptying and provide highly reliable alternatives during weight loss treatment Gastrointestinal side effects such as vomiting within 3 hours of taking oral contraceptives may compromise absorption and require missed pill guidance Weight loss medications should be discontinued before planned conception (typically 12 months depending on the specific agent) Table of Contents How Weight Loss Injections Work in Your Body Weight loss injections prescribed in the UK typically contain glucagon-like peptide-1 (GLP-1) receptor agonists, such as semaglutide (Wegovy) or liraglutide (Saxenda), or dual GIP/GLP-1 receptor agonists like tirzepatide

Common adverse effects include: Gastrointestinal Issues: Nausea, vomiting, diarrhoea, and constipation are frequently reported
He has also tried to stay out of the sun and has received fat injections into his face, The Times reported
While both are effective, tirzepatide appears to offer more robust outcomes in terms of weight loss and glycaemic control, likely due to its dual mechanism
In VRK2-high tumors, VRK2 promotes SLC7A11 trafficking from the ER to the Golgi, enhancing GSH synthesis and conferring resistance to GSH inhibition
HYGIENE A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES A61K9/00Medicinal preparations characterised by special physical form A61K9/14Particulate form, e.g